EnteroBiotix will be attending BioTrinity, London on 23/24 April 2024.

Our CEO Dr James McIlroy presents at BioEquity covering the potential of our premier full-spectrum, microbiome product platform which prevents and treats disease through the restoration and enhancement of gut microbial ecology.

This Boston based event is the most comprehensive forum for microbiome drug developers. Email us to arrange meeting up at the event.

BioTrinity is an established, must-attend London conference, that catalyses growth and supports in-person re-engagement across the life sciences industry. Email us to arrange meeting up at the event.